Meredith Hirsh Meredith Hirsh

Oversight Slips into Permission as Big Insurance Outplays the Federal Watchdog

The federal government loves to say it “oversees” Big Insurance.

In reality, it often supervises from a safe distance while insurers engineer aggressive workarounds in plain sight. Chris Deacons latest Substack piece on Anthem’s Federal Employees Health Benefits Program contract reads like a sharp case study in how power quietly shifts from the regulator to the regulated.

Read More
Meredith Hirsh Meredith Hirsh

Big Weed Is the Next Big Tobacco Hijacking Gen Z Brains

I’m watching something heartbreaking happen to Gen Z, and it’s not just on their phones.

It’s in their brains.

On my latest Working Healthcare podcast episode, “Wine, Weed and the Next Generation,” I sit down with my Zoomer son to ask why he calls high-THC cannabis “the stupid drug” of his generation — and how we are on course to destroy his entire peer group.

Read More
Meredith Hirsh Meredith Hirsh

Can Independent Rheumatology Still Win?

‍ ‍

Rheumatology hasn’t been “gobbled up” yet (Thanksgiving pun fully intended), but after reading the latest Becker's Healthcare’s analysis on physician M&A, it’s clear we’re on the menu. A handful of massive healthcare organizations are redrawing the physician landscape through aggressive acquisitions, vertical integration and high-stakes partnerships.

‍Here’s the part that should make every independent rheumatologist sit up.

‍ ‍

Read More
Meredith Hirsh Meredith Hirsh

America’s Most Expensive Broken System

We all know it — American health care costs more than any other nation. Nobody working inside the system needs another headline to prove that point. We see it in the denials, the administrative bloat, the endless billing gymnastics we perform just to keep the lights on. But it’s worth asking: why does it cost so much?

Read More
Meredith Hirsh Meredith Hirsh

2026 Medicare Part D Drug Changes You Can’t Ignore

Must-know for Medicare open enrollment: the $2,100 cap, smoothing — and the self-administered drug trap

Open enrollment runs Oct. 15 - Dec. 7. Your 2026 playbook needs three pivots that hit adherence, scheduling and cash flow.

Read More
Meredith Hirsh Meredith Hirsh

10 Rules for Entrepreneurial Success

I have owned a medical practice for over a decade, 12 years and 2 months to be precise. I have certainly made some bad decisions, but one must learn from a mistake in order to make it a learning opportunity. Fortunately, I have made more good decisions than bad ones, thus I claim success. To share my success story with others allows for me to continue to ingrain the learning opportunities I have experienced. While I am a mother, University instructor, medical practice Vice President, and business owner, I aspire to inspire and mentor my children, students, employees, colleagues and those I continue to meet along life’s journey.

Read More
Meredith Hirsh Meredith Hirsh

Denied but Not Defeated: How to Appeal an Insurance Denial—and Win

Did you know that less than 1% of denied insurance claims are appealed—but more than 50% of those that are, actually succeed? That stat alone should give every patient hope. It’s a reminder that when insurance says “no,” that doesn’t mean the fight is over. In fact, it’s often just the beginning.

Read More
Meredith Hirsh Meredith Hirsh

What COVID-19 Taught Us about Risk and Crisis Management

Risk is inevitable, but how you assess risk and manage a crisis is essential to the success of your business. Many of us are so hyper-focused on the myriad of variables associated with providing quality patient care that we forget we are in the business of healthcare.

Read More